DataMeds AI, Inc. Increase (Decrease) in Inventories
DataMeds AI, Inc. (MEDS) reported Increase (Decrease) in Inventories of -$56.34 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-17
- DataMeds AI, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$130.51K.
- DataMeds AI, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was $74.17K, a 65.42% decline year-over-year.
- DataMeds AI, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was $135.78K.
- DataMeds AI, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.54M, a 501.72% decline year-over-year.
- DataMeds AI, Inc. increase (decrease) in inventories for fiscal 2025 was -$1.89M, a 2713.36% decline from fiscal 2024.
- DataMeds AI, Inc. increase (decrease) in inventories for fiscal 2024 was $72.36K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$130.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$56.34K 10-Q · filed 2026-08-17 | $79.45K derived: sum of 3 quarters · filed 2026-08-17 | -$1.46M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $74.17K 10-Q · filed 2026-05-19 | $209.96K derived: sum of 2 quarters · filed 2026-05-19 | -$1.33M derived: sum of 3 quarters · filed 2026-05-19 | -$2.03M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $135.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$1.40M derived: sum of 2 quarters · filed 2026-03-20 | -$2.11M derived: sum of 3 quarters · filed 2026-08-17 | -$1.89M 10-K · filed 2026-03-20 |
| 2025-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$2.24M derived: sum of 2 quarters · filed 2026-08-17 | -$2.03M 10-Q · filed 2025-11-19 | -$2.32M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$701.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$487.46K 10-Q · filed 2026-08-17 | -$782.17K derived: sum of 3 quarters · filed 2026-08-17 | -$399.01K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $214.47K 10-Q · filed 2026-05-19 | -$80.23K derived: sum of 2 quarters · filed 2026-05-19 | $302.93K derived: sum of 3 quarters · filed 2026-05-19 | |
| 2024-12-31 | -$294.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $88.46K derived: sum of 2 quarters · filed 2026-03-20 | $72.36K 10-K · filed 2026-03-20 | |
| 2024-09-30 | $383.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $367.06K 10-Q · filed 2025-11-19 | ||
| 2024-06-30 | -$16.10K 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |